Spencer et al. (1993) Science 262:1019-1024. |
Travis (1993) Science 262:989. |
Nakamura et al. (1994) Nature 369: 330-333. |
Heinzel et al., Use of Simian Virus 40 replication to amplify Epstein-Barr virus shuttle vectors in human cells, J. Virol. 62:3738-3746 (1988). |
Kishimoto et al., Cytokine Signal Transduction, Cell 76:253-262 (1994). |
Miyazaki et al., Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits, Science 266:1045-1047 (1994). |
Morgan and Anderson, Human Gene Therapy, Ann. Rev. Biochem. 62:191-217 (1993). |
Mulligan, The Basic Science of Gene Therapy, Science 360:926-930 (1993). |
Niehuis et al., Gene Transfer into Hematopoietic Stem Cells, Cancer 67:2700-2704 (1991). |
Paul, Tumor Immunology, Fundamental Immunol., Chap. 34, pp. 923-955 (1989). |
Orkin et al., Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy (1995). |
Riddell et al., Genetically Modified T-Cell Clones as a Treatment for Human Viral Diseases, Soc. Biol. Therapy, (Meeting Abstract), p. 50 (1993). |
Sakai et al., Signal Transduction by a CD16/CD7/Jak2 fusion Protein, J. Biol. Chem. 270:18420-18427 (1995). |
Stancovski et al., Targeting of T Lymphocytes to Neu/Her-2-expressing Cells using chimeric Single Chain Fv Receptors, J. Immunol. 151:6577-6582 (1993). |
Weatherall, Scope and limitations of Gene Therapy, British med. Bull. 51:1-11 (1995). |